We have located links that may give you full text access.
Additive Benefit of Radiomics Over Size Alone in the Distinction Between Benign Lesions and Luminal A Cancers on a Large Clinical Breast MRI Dataset.
Academic Radiology 2018 May 11
RATIONALE AND OBJECTIVES: The objective of this study was to demonstrate improvement in distinguishing between benign lesions and luminal A breast cancers in a large clinical breast magnetic resonance imaging database by using quantitative radiomics over maximum linear size alone.
MATERIALS AND METHODS: In this retrospective study, 212 benign lesions and 296 luminal A breast cancers were automatically segmented from dynamic contrast-enhanced breast magnetic resonance images. Thirty-eight radiomic features were extracted. Tenfold cross validation was performed to assess the ability to distinguish between lesions and cancers using maximum linear size alone and lesion signatures obtained with stepwise feature selection and a linear discriminant analysis classifier including and excluding size features. Area under the receiver operating characteristic curve (AUC) was used as the figure of merit.
RESULTS: For maximum linear size alone, AUC and 95% confidence interval was 0.797 (0.754, 0.835) compared to 0.846 (0.808, 0.875) (P = .005) and 0.848 (0.811, 0.880) (P = .003) for lesion signature feature selection protocols including and excluding size features, respectively. The irregularity feature was chosen in 9 of 10 folds and in all folds when size features were included and excluded, respectively. AUC for the radiomic signature using feature selection from all features was statistically equivalent to using feature selection from all features excluding size features, within an equivalence margin of 2%.
CONCLUSIONS: Inclusion of multiple radiomic features, automatically extracted from magnetic resonance images, in a lesion signature significantly improved the ability to distinguish between benign lesions and luminal A breast cancers, compared to using maximum linear size alone. The radiomic feature of irregularity appears to play an important but not a solitary role within the context of feature selection and computer-aided diagnosis.
MATERIALS AND METHODS: In this retrospective study, 212 benign lesions and 296 luminal A breast cancers were automatically segmented from dynamic contrast-enhanced breast magnetic resonance images. Thirty-eight radiomic features were extracted. Tenfold cross validation was performed to assess the ability to distinguish between lesions and cancers using maximum linear size alone and lesion signatures obtained with stepwise feature selection and a linear discriminant analysis classifier including and excluding size features. Area under the receiver operating characteristic curve (AUC) was used as the figure of merit.
RESULTS: For maximum linear size alone, AUC and 95% confidence interval was 0.797 (0.754, 0.835) compared to 0.846 (0.808, 0.875) (P = .005) and 0.848 (0.811, 0.880) (P = .003) for lesion signature feature selection protocols including and excluding size features, respectively. The irregularity feature was chosen in 9 of 10 folds and in all folds when size features were included and excluded, respectively. AUC for the radiomic signature using feature selection from all features was statistically equivalent to using feature selection from all features excluding size features, within an equivalence margin of 2%.
CONCLUSIONS: Inclusion of multiple radiomic features, automatically extracted from magnetic resonance images, in a lesion signature significantly improved the ability to distinguish between benign lesions and luminal A breast cancers, compared to using maximum linear size alone. The radiomic feature of irregularity appears to play an important but not a solitary role within the context of feature selection and computer-aided diagnosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app